Metronidazole La Colina (Metronidazole)

Metronidazole is a nitroimidazole agent that targets anaerobic bacteria and protozoal organisms. It is employed in several well‑established clinical situations:

• Bacterial vaginosis: restores normal vaginal flora by eradicating anaerobic pathogens.
• Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing transmission.
• Amoebiasis: clears intestinal Entamoeba histolytica infection and associated liver abscesses.
• Anaerobic bacterial infections (intra‑abdominal, pelvic, skin and soft‑tissue): provides bactericidal activity against mixed anaerobic flora.
• Clostridioides difficile infection (adjunct therapy): reduces toxin‑producing bacterial load when used with standard therapy.

• Metronidazole is reduced inside anaerobic microorganisms, generating reactive nitro radicals that damage DNA and inhibit nucleic acid synthesis. This leads to strand breakage and cell death, selectively targeting organisms that thrive in low‑oxygen environments while sparing most aerobic human cells.

Metronidazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Metallic taste: transient metallic sensation in the mouth.
• Diarrhea: loose stools that may be watery.
• Abdominal pain: cramping or discomfort in the stomach area.
• Headache: mild to moderate headache.
• Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects

• Seizures: convulsions, particularly with high doses or rapid infusion.
• Peripheral neuropathy: tingling or numbness in extremities.
• Severe allergic reactions: rash, swelling, anaphylaxis.
• Stevens‑Johnson syndrome: severe skin blistering and detachment.
• Hepatitis: liver inflammation with jaundice.
• Neutropenia: marked reduction in white blood cells.

Before initiating therapy, clinicians should consider several safety aspects.

• Assess renal function: dose adjustment may be needed in renal impairment.
• Monitor hepatic function: avoid use in severe liver disease.
• Avoid alcohol: risk of disulfiram‑like reaction.
• Use caution in pregnancy: only if benefits outweigh potential risks.
• Use caution in patients with CNS disorders: may lower seizure threshold.
• Store at room temperature: keep in the original pack, protect from moisture.

Metronidazole can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Alcohol: may cause severe flushing, tachycardia, and hypotension.
• Warfarin: potentiates anticoagulant effect, increasing bleeding risk.
• Lithium: may raise lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: may reduce hormonal efficacy, consider backup method.
• Cimetidine: can increase metronidazole plasma concentrations.
• Carbamazepine: may lower metronidazole levels, reducing therapeutic effect.